skip to main content

COVID-19 Information and Guidance

Stem Cell Tourism Near and Far: Achieving a Compromise for the Patient

Stem Cell Tourism Near and Far: Achieving a Compromise for the Patient

Patient advocacy groups have been strong supporters of stem cell and regenerative medicine research. But, after waiting more than a decade for scientists to complete clinical trials, many patients are now approaching clinics around the world that offer experimental stem cell-based interventions. Why did patients who were once strong supporters of stem cell research become stem cell tourists? And how can scientists, clinicians and regulators work to bring stem cell patients back to the U.S. and into the clinical trial process?

This panel discussion combined the perspectives of a physician scientist, policy scholar, bioethicist and regulator to explore the risks surrounding stem cell tourism. Panelists examined the FDA’s efforts to combat the issue within the U.S. and why the clinical trial process is the gold standard for understanding the impact of therapeutic interventions. The dialogue aimed to highlight options for better cooperation and collaboration with the FDA to expedite proven therapies.

This event was sponsored by the Baker Institute Center for Health and Biosciences and the Texas Heart® Institute.

Join the conversation online with #BakerStemCell







7:30 am



Breakfast and Registration

8:00 am



Welcome and Introduction

Vivian Ho, Ph.D.
James A. Baker III Institute Chair in Health Economics and Director, Center for Health and Biosciences, Baker Institute





Moderator: Vivian Ho, Ph.D.

James T. Willerson, M.D.President and Director, Cardiology Research, and Co-director, Cullen Cardiovascular Research Laboratories, Texas Heart® Institute

Joyce L. Frey-Vasconcells, Ph.D.
President and Regulatory Expert, Frey-Vasconcells Consulting, LLC 

Kirstin R.W. Matthews, Ph.D.
Fellow in Science and Technology Policy, Baker Institute

Ana S. Iltis, Ph.D.
Nonresident Scholar, Center for Health and Biosciences, Baker Institute;
Director, Center for Bioethics, Health and Society, and Professor of Philosophy, Wake Forest University

Question and Answer Session

 9:20 am



Closing Remarks






Thu, Sept. 22, 2016
7:30 a.m. - 9:30 a.m.
(GMT-0500) US/Central

Event has ended


James A. Baker III Hall, Rice University
6100 Main St.
Houston, Texas 77005

Doré Commons